BARRY DASH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ELITE PHARMACEUTICALS INC /NV/

Filing Date Source Excerpt
2008-05-09 DR. BARRY DASH, Director since April 2005, Member of the Audit Committee since April 2005, Member of the Nominating Committee since April 2005 and Member of the Compensation Committee since June 2007.
2008-11-21 Barry Dash, Director*
2011-08-31 Dr. Barry Dash has served as a Director since April 2005, Member of the Audit Committee since April 2005, Member of the Nominating Committee since April 2005 and Member and Chairman of the Compensation Committee since June 2007. The Audit Committee members were Jeffrey Whitnell (Chairman of the Audit Committee), Barry Dash and Ram Potti. The Nominating Committee members were Ram Potti (Chairman), Jeenarine Narine and Barry Dash. The Compensation Committee members were Barry Dash (Chairman), Ashok Nigalaye and Jeffrey Whitnell. Director compensation table shows Barry Dash fees earned or paid in cash $9,125, stock awards $25,000, and all other compensation $5,000 totaling $39,125.
2020-04-29 Barry Dash, Director*

Data sourced from SEC filings. Last updated: 2026-03-05